Subscribe
istock-840333528_phonlamaiphoto
PhonlamaiPhoto / iStockphoto.com
18 October 2018Americas

US agencies to bolster cybersecurity of medical devices

The US Food and Drug Administration (FDA) has announced that it has partnered with the US Department of Homeland Security (DHS) as part of the FDA’s aim to strengthen cybersecurity in healthcare.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FDA seeks revamp of medical devices approvals
27 November 2018   The US Food and Drug Administration is set to change the way that medical devices are approved, after 42 years.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

More on this story

Americas
FDA seeks revamp of medical devices approvals
27 November 2018   The US Food and Drug Administration is set to change the way that medical devices are approved, after 42 years.

More on this story

Americas
FDA seeks revamp of medical devices approvals
27 November 2018   The US Food and Drug Administration is set to change the way that medical devices are approved, after 42 years.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?